Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 September 2023 | Story Nicole Bongo | Photo Supplied
GBV dialogue 2023
The UFS Xhosa Student Association and Gender Equality and Anti-Discrimination Office joined forces to host a dialogue to enlighten students on combating gender-based violence.

The Xhosa Student Association at the University of the Free State (UFS), along with the UFS Gender Equality and Anti-Discrimination Office (GEADO) on its Bloemfontein Campus, recently hosted a dialogue titled ‘Aiding the Victim’, to educate students about what perpetuates gender-based violence, and inform them about UFS support services available to help fight GBV.

The discussion was held at the Education Auditorium on 25 August 2023, and students were challenged to pinpoint what GBV is and what it looks like. Balisa Nqambuza, Chairperson of the Xhosa Student Association and second-year BA student majoring in psychology and philosophy, said, “There is a need to have these tough conversations, as they provide insight on how to combat GBV in the future... We have had enough talks about the problem, and it is very important to start speaking about solutions that inform people of what they can do when encountering GBV.” 

The event organisers said the dialogue was an opportunity for GEADO and the Xhosa Student Association to inform students about support structures within the university that provide help for students through free counselling sessions.

“The objective was to bring awareness about GBV victims amongst us, and how to assist them better, and to also highlight comprehensive approaches, as dialogues may discuss holistic approaches that address the multidimensional impact of GBV, including psychological, emotional, physical, and economic consequences,” said Pebetsi Kgole, a guest speaker and intern from GEADO.

In May 2023, the United Nations International Children's Emergency Fund reported a shocking rise in violence against women in South Africa, with 969 murders and 1 485 attempted murders recorded over this period. The UFS has put many structures in place to help in the fight against the scourge of GBV. 

Other support services available include a sexual offense response team made up of GEADO, Protection Services, Kovsie Health, access to psychologists and social workers, and free services to help victims feel safe in a secure environment. 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept